£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Lung Cancer Screening Software Outlook 2023-2028 Report

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 87 days · 87 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 24 August 2026 15 September 2026 06 October 2026 28 October 2026
View at Amazon ↗

Price data checked 4 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 87 days • 1 price levels

Days at Price
87 days 0 22 44 65 87 £490 Days at Price

Price Analysis

Most common price: £490 (87 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 87 days

Description

This comprehensive study provides a detailed outlook for the lung cancer screening software market from 2023 to 2028. It analyzes latent demand across the United States, providing potential industry earnings (P.I.E.) estimates for 10,833 specific zip codes. By offering granular data, this report helps professionals understand market opportunities at a local level. Each zip code includes a reported percent share relative to its state and the entire United States. These comparative benchmarks allow for quick assessments of specific areas against others. This statistical approach serves as a practical tool for developing distribution plans and optimizing sales force strategies across various U.S. regions.

Key Features

Provides latent demand outlook and potential industry earnings (P.I.E.) estimates for lung cancer screening software through 2028.

Includes detailed market data covering 10,833 zip codes across various states in the United States.

Offers comparative benchmarks by reporting the percent share of each zip code relative to its state and the total U.S. market.

Supports the development of effective distribution and sales force strategies through granular statistical analysis.

Delivers specific financial estimates in millions of U.S. dollars to help gauge market potential in different geographic areas.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Lung Cancer Screening Software in China
99% match

The 2023-2028 Outlook for Lung Cancer Screening Software in China

£495.00 17 Oct 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
99% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in Japan
99% match

The 2023-2028 Outlook for Lung Cancer Screening Software in Japan

£495.00 28 Oct 2026
The 2023-2028 World Outlook for Lung Cancer Screening Software
98% match

The 2023-2028 World Outlook for Lung Cancer Screening Software

Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in India
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in India

£515.00 21 Aug 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in the United States
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in the United States

£520.00 19 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 02 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan

£495.00 26 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
98% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

£790.00 21 Aug 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
98% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 01 Oct 2026
The 2023-2028 World Outlook for Non-Small Cell Lung Cancers
97% match

The 2023-2028 World Outlook for Non-Small Cell Lung Cancers

Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 26 Sep 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 01 Oct 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
97% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
The 2021-2026 World Outlook for Lung Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Lung Cancer Therapeutics

£795.00 18 Aug 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
97% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 27 Sep 2026
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
97% match

NSCLC Therapeutics Outlook in Asia (2013-2018) Study

£325.00 27 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 01 Oct 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
97% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 28 Oct 2026